How are oligo therapeutics revolutionising genetic disease treatments through precise targeting and transformative therapies? In this article, we explore how they provide precise gene expression interference for untreatable conditions by directly targeting disease-associated proteins and genetic mutations.

As cancer treatments continue to develop, bispecific cell engagers are revolutionising this therapeutic landscape.